Biomedical Engineering Reference
In-Depth Information
77 Ebihara Y, Masuya M, LaRue AC, Fleming PA, Visconti RP, Minamiguchi D, Drake CJ
and Ogawa M, 'Hematopoietic origins of fibroblasts: II.
In vitro
studies of fibroblasts,
CFU-F, and fibrocytes',
Exp Hematol
, 2006,
34
(2), 219-29.
78 Pittenger MF and Martin BJ, 'Mesenchymal stem cells and their potential as cardiac
therapeutics',
Circ Res
, 2004,
127
(6), 1101-4.
79 Cha J and Falanga V, 'Stem cells in cutaneous wound healing',
Clin Dermatol
, 2007,
25
(1), 73-8.
80 Kemp KC, How J and Donaldson C, 'Bone marrow-derived mesenchymal stem cells',
Leuk Lymphoma
, 2005,
46
(11), 1531-44.
81 Goessler UR, Riedel K, Hormann K and Riedel F, 'Perspectives of gene therapy in stem
cell tissue engineering',
Cells Tissues Organs
, 2006,
183
(4), 169-79.
82 Barry FP and Murphy JM, 'Mesenchymal stem cells: clinical applications and biological
characterization',
Int J Biochem Cell Biol
, 2004,
36
(4), 568-84.
83 LeBlanc K and Ringden O, 'Mesenchymal stem cells: properties and role in clinical bone
transplantation',
Curr Opin Immunol
, 2006,
18
(5), 586-91.
84 Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK and Dahlke MH,
'Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model',
Transplantation
, 2006,
81
(11), 1589-95.
85 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA,
Simonetti DW, Craig S and Marshak DR, 'Multilineage potential of adult human
mesenchymal stem cell',
Science
, 1999,
2284
(5411), 143-7.
86 Nandoe RD, Hurtado A, Levi AD, Crotenhuis A and Oudega M, 'Bone marrow stromal
cells for repair of the spinal cord: towards clinical application',
Cell Transplant
, 2006,
15
(7), 563-77.
87 The National Institutes of Health, 'Hematopoietic stem cells', in
Stem Cells: Scientific
Progress and Future Research Directions
, 2001, 43-58. (http://stemcells.nih.gov/info/
scireport/chapter5.asp)
88 Mori L, Bellini A, Stacey MA, Schmidt M and Mattoli S, 'Fibrocytes contribute to the
myofibroblast population in wounded skin and originate from the bone marrow',
Exp
Cell Res
, 2005,
394
(1), 81-90.
89 Laurent GJ, Chambers RC, Hill MR and McAnulty RJ, 'Regulation of matrix turnover:
fibroblasts, forces, factors and fibrosis',
Biochem Soc Trans
, 2007,
35
(Pt 4), 647-51.
90 Lama VN and Phan SH, 'The extrapulmonary origin of fibroblasts: stem/progenitor cells
and beyond',
Proc Am Thorac Soc
, 2006,
3
(4), 373-6.
91 Hashimoto N, Jin H, Liu T, Chensue SW and Phan SH, 'Bone marrow-derived progenitor
cell in pulmonary fibrosis',
J Clin Invest
, 2004,
113
(2), 243-52.
92 Allan DS, Dube P, Roy J, Busque L and Roy DC, 'Endothelial-like vascular progenitor
cells (VPCs) from allogenic and autologous donors: mobilization features distinct from
hematopoietic progenitors',
Biol Blood Marrow Trans
, 2007,
13
(4), 433-9.
93 Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ,
Witte L, Moore MA and Rafii S, 'Expression of VEGFR-2 and AC133 by circulating
human CD34 (+) cells identifies a population of functional endothelial precursors',
Blood
, 2000,
95
(3), 952-8.
94 Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM
and Asahara T
, '
Ischemia- and cytokine-induced mobilization of bone marrow-derived
endothelial progenitor cells for
neovascularization',
Nat Med
, 1999,
5
(4), 434-8.
95 Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M and Suda T,
'A role for hematopoietic stem cells in promoting angiogenesis',
Cell
, 2000,
102
(2),
199-209.
